| P50 | author | Juan J Gómez-Reino | Q88208653 |
| P2093 | author name string | M. R. Gonzalez-Crespo | |
| P2860 | cites work | In vitro and in vivo antifungal activities of BMY-28864, a water-soluble pradimicin derivative | Q28325702 |
| | Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation | Q28333954 |
| | The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies | Q30434030 |
| | Infection in immunocompromised patients | Q93583581 |
| | Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon | Q123345942 |
| | Acute pancreatitis in systemic lupus erythematosus: report of a case unrelated to drug therapy | Q33560633 |
| | Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease | Q33604267 |
| | Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation | Q34498204 |
| | Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis | Q34622519 |
| | Damage to hyphal forms of fungi by human leukocytes in vitro. A possible host defense mechanism in aspergillosis and mucormycosis | Q36058540 |
| | Chronic necrotising pneumonia caused by Aspergillus niger | Q36201413 |
| | Nonresolving pneumonia in steroid-treated patients with obstructive lung disease | Q36304473 |
| | Diagnosing fungal infections in immunocompromised hosts | Q36778861 |
| | Cryptococcal meningitis as a complication of systemic lupus erythematosus treated with systemic corticosteroids | Q36809143 |
| | Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes | Q37008593 |
| | A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus | Q37029462 |
| | 10 year review of invasive aspergillosis detected at necropsy | Q37141726 |
| | Problems in the Diagnosis of Invasive Fungal Diseases | Q37229869 |
| | Systemic fungal infections: an overview | Q37320914 |
| | Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. | Q38016840 |
| | Problems in management of opportunistic fungal diseases | Q38260951 |
| | Immunosuppressive effects and infections associated with corticosteroid therapy | Q39515302 |
| | Interferon-gamma, the activated macrophage, and host defense against microbial challenge | Q39601454 |
| | Neutrophils and host defense | Q39647006 |
| | Aspergillosis. The spectrum of the disease in 98 patients | Q39990857 |
| | Opportunistic infection and interstitial pneumonia following marrow transplantation for aplastic anemia and hematologic malignancy | Q40029448 |
| | Fungal and yeast infections of the central nervous system. A clinical review. | Q40170984 |
| | Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. | Q40326316 |
| | Fever in systemic lupus erythematosus | Q40730853 |
| | Aspergillosis in the acquired immunodeficiency syndrome | Q40741767 |
| | Salmonellosis and systemic lupus erythematosus. Report of ten cases | Q40742923 |
| | Pulmonary aspergillosis in the acquired immunodeficiency syndrome | Q40750770 |
| | Oral azole drugs as systemic antifungal therapy | Q40796244 |
| | Prognostic indicators in fungemia of the surgical patient | Q40819121 |
| | Fungal infections in patients with acute leukemia | Q40841874 |
| | The renal transplant patient with fever and pulmonary infiltrates: etiology, clinical manifestations, and management | Q40861644 |
| | Pulmonary Infections in Renal Transplant Recipients | Q40865026 |
| | Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis | Q41006215 |
| | Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus | Q41364293 |
| | Experience of invasive aspergillosis in Hong Kong | Q42345678 |
| | Fatal pulmonary aspergillosis presenting as acute eosinophilic pneumonia in a previously healthy child | Q43431259 |
| | A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation | Q43619964 |
| | The bimodal mortality pattern of systemic lupus erythematosus | Q43703475 |
| | The role of fluconazole in the early treatment and prophylaxis of experimental invasive aspergillosis | Q43767887 |
| | Operation for cavitating invasive pulmonary aspergillosis in immunocompromised patients | Q43797171 |
| | Systemic lupus erythematosus and infection: a controlled and prospective study including an epidemiological group | Q43947755 |
| | Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus | Q44489164 |
| | Infection in patients with systemic lupus erythematosus. Association with a serum inhibitor of complement-derived chemotactic activity | Q44794843 |
| | Impairment of neutrophil antifungal activity against hyphae of Aspergillus fumigatus in children infected with human immunodeficiency virus | Q45773730 |
| | Treatment of invasive aspergillosis with itraconazole | Q46380526 |
| | Pulmonary aspergillosis due to Aspergillus terreus combined with staphylococcal pneumonia and hepatic candidiasis | Q46461419 |
| | Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms. | Q46970545 |
| | Central nervous system aspergillosis following steroidal therapy for allergic bronchopulmonary aspergillosis | Q48365617 |
| | Purulent meningitis due to aspergillosis in a patient with systemic lupus erythematosus | Q48599723 |
| | Toxoplasmosis in the central nervous system | Q48686744 |
| | Use of bronchoalveolar lavage in immunocompromised children with pneumonia. | Q51193341 |
| | Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS. | Q51195851 |
| | The use of amphotericin B in nosocomial fungal infection. | Q51196891 |
| | Invasive aspergillosis. Progress in early diagnosis and treatment. | Q51198301 |
| | Inhibition of complement by culture supernatants of Aspergillus fumigatus. | Q53884721 |
| | Infectious keratitis and cyanoacrylate adhesive. | Q54298178 |
| | In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. | Q54423329 |
| | Mechanisms of resistance of Aspergillus fumigatus Conidia to killing by neutrophils in vitro. | Q54448209 |
| | In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae | Q57908432 |
| | Fungal infection in chronic granulomatous disease | Q57908583 |
| | Fungal diseases in a general hospital; a study of 88 patients. | Q64992961 |
| | Bronchoalveolar lavage. Let's focus on clinical utility | Q67589488 |
| | Diagnostic value of hemosiderin-containing macrophages in bronchoalveolar lavage | Q67589506 |
| | Protective effect of human granulocyte colony-stimulating factor (hG-CSF) on Cryptococcus and Aspergillus infections in normal and immunosuppressed mice | Q67710891 |
| | Overwhelming fatal infection in a young woman after intravenous cyclophosphamide therapy for lupus nephritis | Q67896313 |
| | Fluconazole failure in the treatment of invasive mycoses | Q68064113 |
| | Aspergillus antigen latex test for diagnosis of invasive aspergillosis | Q68319651 |
| | Aspergillosis complicating neoplastic disease | Q68652920 |
| | Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids | Q68926740 |
| | Aspergillosis | Q69216244 |
| | Primary cutaneous aspergillosis associated with Hickman intravenous catheters | Q69406350 |
| | The compromised host as sentinel chicken | Q69406359 |
| | Invasive pulmonary aspergillosis in nonimmunocompromised, nonneutropenic hosts | Q69557235 |
| | Incidence of infection in systemic lupus erythematosus | Q69733299 |
| | Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma | Q69830931 |
| | Phagocytic and fungicidal activity of monocytes from patients with acquired immunodeficiency syndrome | Q70061687 |
| | Immunoblot analyses of the serologic response to Aspergillus fumigatus antigens in experimental invasive aspergillosis | Q70164210 |
| | A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death | Q70245059 |
| | Disseminated aspergillosis in a presumably immunocompetent host | Q70255540 |
| | Infection in Immunologically-mediated Diseases: A Review | Q70264308 |
| | Invasive aspergillosis | Q70311114 |
| | A case of fulminant systemic lupus erythematosus complicated by severe aspergillar septicemia confirmed by pathologic findings | Q70320904 |
| | Diagnostic success of bronchoscopic biopsy in immunocompromised patients with acute pulmonary disease: predictive value of disease distribution as shown on CT | Q70521035 |
| | The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients | Q70992711 |
| | Invasive aspergillosis of the lung and pericardium in a nonimmunocompromised 33 year old man | Q70992752 |
| | Acquired immune deficiency syndrome: is disseminated aspergillosis predictive of underlying cellular immune deficiency? | Q71008640 |
| | Pulmonary nocardiosis. Occurrence in men with systemic lupus erythematosus | Q71153493 |
| | Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia | Q71268640 |
| | Invasive pulmonary aspergillosis in an apparently nonimmunocompromised host | Q71347799 |
| | Fungus Infection in Steroid-Treated Systemic Lupus Erythematosus | Q72143643 |
| | The course of systemic lupus erythematosus | Q72767434 |
| | Combination therapy in experimental invasive aspergillosis | Q72888278 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | aspergillosis | Q259626 |
| | invasive aspergillosis | Q3625278 |
| | systemic lupus erythematosus | Q1485 |
| P304 | page(s) | 304-314 | |
| P577 | publication date | 1995-04-01 | |
| P1433 | published in | Seminars in Arthritis and Rheumatism | Q15761553 |
| P1476 | title | Invasive aspergillosis in systemic lupus erythematosus | |
| P478 | volume | 24 | |